# OnCo record optimice-pcr (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/optimice-pcr/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "optimice-pcr", "NCT05812807" ;
  schema:name "OptimICE-pCR (A012103)"@en ;
  schema:description "Asks whether patients whose cancer completely disappeared before surgery still need a year of immunotherapy afterwards."@en ;
  schema:url <https://onco.cc/trials/optimice-pcr/> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT05812807> ;
  onco:status "recruiting" ;
  onco:phase "3" ;
  schema:startDate "2023-06-14" ;
  onco:cancers <https://onco.cc/cancers/tnbc/> ;
  onco:technologies <https://onco.cc/technologies/checkpoint-inhibitor/> ;
  onco:drugs <https://onco.cc/drugs/pembrolizumab/> ;
  onco:companies <https://onco.cc/companies/alliance-oncology/> ;
  onco:terms <https://onco.cc/terms/pcr/> .
